Abstract
Introduction and Importance
Cushing's syndrome is a rare condition caused by the long-term glucocorticoid exposure. The clinical picture is variable in severity and presentation. All form of steroid use (parenteral, topical, inhalational as well as additive in herbal and other formulations) are responsible for causing iatrogenic Cushing syndrome.
Case
We present a case of 59 year male from rural Nepal who initiated prednisolone 10mg per day for trivial joint pain over the counter (OTC) for 14 years presented with acute cellulitis of arm and long term changes of steroid overuse. This study is directed to alarm the importance of medical history review and management.
Clinical findings and investigations
Patient had features of florid Cushing syndrome and joint line tenderness of bilateral knee along with lumbar vertebral tenderness.ACTH level, Abdominal ultrasonography, imaging of knee and thoracolumbar spine was sent for diagnosis.
Intervention and outcome
Patient was manged with analgesics, antibiotics, alternate day dressings and referred to orthopaedics for further management of osteoarthritic changes.
Conclusion
To prevent such catastrophic event topical steroids and their mixtures must be sold as "prescription-only" medications and physicians must take detailed history prior to management and correct the irrational use of drugs like Steroids.
Keywords: Steroid, Osteoporosis, Osteoarthritis, Case report, Long term effects
Highlights
-
•
Cushing's syndrome is caused by the long-term glucocorticoid exposure.
-
•
Patient has presented to opd with cellulitis.
-
•
Detailed History Taking revealed long term use of OTC Steroid.
-
•
Patient was managed with Antibiotics and analgesics for cellulitis and referred to Orthopedics and Physiotherapist for Osteoarthritis.
1. Introduction
1.1. Background and rationale
Nepal is a developing country in south Asia where health care system is run by both public and private sectors and yet considered unable to maintain international standard. And there is huge health care disparities in rural and urban area regarding resources which led to substandard treatment in various time period.
Corticosteroid is a magic bullet discovered in modern medicine. It is widely used for many diseases as anti-inflammatory. However, irrational use of corticosteroid has been increasing every day. According to 2001 report, one percentage of general population was on systemic corticosteroid [1] and among which about two third exhibits iatrogenic Cushing syndrome due to excessive use of the drugs [2]. Sadly, we have multiple unauthorized prescriptions and OTC availability of steroids in rural part of our country. So, it is absolute necessary for treating physicians to look over the patient medical and drug history. We present a case of preventable adverse drugs reaction in a patient.
2. Case report
2.1. Patient information
2.1.1. Demographics and presentation
59 year old male, form rural part of country who is farmer by occupation and have no formal education (cannot read and write any language) presented to out-patient department with the complaints of painful swelling of right fingers since five days. He also mentioned that similar wounds developed with trivial prick or abrasion as well. On further evaluation he said he had gain weight, started severe back and knee pain bilaterally and proximal muscle weakness gradually over time.
2.1.2. Past history
Similar wounds developed on trivial injury on past.
2.1.3. Family history
Non significant family history.
2.1.4. Drug and allergy history
patient reveal taking aceclofenac 100mg and prednisolone 10mg, twice a day since 14 years for non-specific knee pain. It was prescribed by some pharmacist and has been taking till date over the counter (OTC).
2.2. Clinical findings
On examination the patient had features of florid Cushing syndrome (Fig. 1) and joint line tenderness of bilateral knee along with lumbar vertebral tenderness. The right hand is swollen and there was necrotic tissue at the base of middle finger (Fig. 2, Fig. 3). The dorsum of hand also had swallow ulcers which developed after trivial injury in the area. The skin look thin and shiny with normal pulse at radial.
Fig. 1.
Patient from rural part of Nepal with Cushingoid facies.
Fig. 2.
Swollen hand and necrotic skin at the base of middle finger.
Fig. 3.
Ventral surface of right hand showing necrotic tissue at the base of middle finger.
2.3. Diagnostic assessment and interpretation
Laboratory finding revealed low adrenocorticotropic hormone (ACTH) level in the blood measuring 6 pg/ml and low 8 a.m. cortisol level measuring 1.6mcg/dl. Abdominal ultrasonography shows slightly atrophic bilateral adrenal gland. He also had slight liver function derangement and hyperlipidemia but normal blood sugar level. Patient had lymphopenia (5%), neutrophilia (97%) and anemia (11g/dl).
Imaging of knee shows bilateral osteoarthritic changes (Fig. 4) and thoracolumbar imaging also show osteoporotic changes, scoliosis and osteoarthritic changes of steroid. (Fig. 5, Fig. 6).
Fig. 4.
Osteoarthritis of both knee due to steroid overuse.
Fig. 5.
Anteroposterior view of X-ray of dorsolateral spine showing osteoporotic changes, scoliosis and osteoarthritic changes.
Fig. 6.
X ray of lateral view of dorsolateral spine showing osteoporotic and osteoarthritic changes.
Hence diagnosis of iatrogenic Cushing syndrome with complicated cellulitis was made and dressing of wound was done. The patient was counseled regarding steroid misuse but patient pain has increased more so patient was reluctant to change the drug. Dressing of wound reveals sloughs and draining pus which was sent for culture. Gram stain reveals gram positive cocci in clusters and few gram negative rods. Patient was kept in tramadol 50mg prn along with Ampicillin-cloxacillin four times daily for 5days.
2.4. Outcome and followup
On the alternate dressing the wound was drastically improved and granulation tissue started already. Patient is referred for orthopedics and physiotherapist consultation for further management of osteoarthritis.
3. Discussion
Cushing's syndrome is a rare condition caused by the long-term glucocorticoid exposure. The clinical picture is noticeably different [3].The clinical manifestations of Cushing's syndrome differ depending on the gender. Men with Cushing Disease (CD) are more prone to show with more florid clinical symptoms at a younger age. Much more common are striae, muscular weakness and atrophy, osteoporosis, and kidney stones [4], which was present in our study as well except renal stone.
In both men and women, gonadal dysfunction manifests as a loss of libido, infertility, monthly irregularity or amenorrhea in women, and erectile dysfunction in men [5]. Testicular atropy was present in our patient as well.
Patients with ectopic Cushing's syndrome typically have significant hypercortisolemia, hypokalemia, and acute or opportunistic infections, as well as a quick start of symptoms and a florid appearance [5,6,and7]]. These characteristics, on the other hand, suggest the severity of hypercortisolism. But endogenous use of steroid for such a long period has presented with these features which is a tragedy.
In 50%–80% of Cushing's syndrome patients, decreased bone mineral density, osteoporosis, and fractures are prevalent. Bone mineral density improves after cure, although ongoing therapy for fractures and discomfort may be required [8]. Our patient who initiated steroid out of misdiagnosis of joint pain lend up into osteoporotic changes and fracture of spine and osteoarthritis of knee joints.
Psychiatric and cognitive dysfunction is present in 70%–85% of patients with Cushing's syndrome [9], which was not seen in our patient.Excess glucocorticoids cause skeletal muscles, skin, and connective tissue to break down. Increased protein wasting and type II muscle-fiber atrophy are linked to considerable muscular weakening, with the pelvic girdle musculature being the most affected [10,11]. Disuse muscular atrophy and decreased mobility are further exacerbated by vertebral fractures, back discomfort, and depression. Even several years after remission, a consistently decreased quality of life, mainly in the physical area, and permanent muscle weakness have been described [12,13,14,and15]].
Dyslipidemia (increased low-density lipoprotein, decreased high-density lipoprotein) and glucose intolerance occur in 45%–70% of patients [[16], [17], [18]]. Although not usually present, hypertension (cortisol-mediated augmentation of vascular reactivity to vasoconstrictors and cortisol's mineralocorticoid effects) is common in people with Cushing's syndrome, with an estimated frequency of 80% [17,19].
Endogenous Cushing's syndrome has traditionally been characterized as either ACTH-dependent or ACTH-independent. Cushing's syndrome caused by ACTH is responsible for 80–85% of cases. 75–80% of these are caused by ACTH production from a pituitary adenoma (Cushing's disease [CD]), 15%–20% are caused by ACTH production from non-pituitary tumors (ectopic ACTH syndrome [EAS]), and 1% are caused by corticotrophin-releasing hormone (CRH)-producing tumors [20,21]. The most common cause of Cushing's syndrome (exogenous or iatrogenic Cushing's syndrome) is the use of supraphysiologic dosages of glucocorticoids [22].
A complete medication history is required because glucocorticoids are used to treat inflammatory, autoimmune, and neoplastic illnesses. Although oral glucocorticoids are the most typically associated with iatrogenic Cushing's disease, any form of delivery should be considered, including inhalation, topical, or injectable glucocorticoids [23,24,and25]]. Megetrol acetate or high dosage medroxy progesterone, a progestin with considerable inherent glucocorticoid activity, can also cause it [26]. Ritonavir causes cushing syndrome by delaying the clearance of some inhaled steroids [27]. The use of glucocorticoid-containing lotions or herbal medicines can potentially produce Cushing syndrome [28,29].
Community pharmacists play an essential role in Nepalese health care, handling prescriptions, providing primary support, and referring patients to higher levels of care. Patients visit community pharmacies before and after their doctor visits to receive drugs and drug information because they are a convenient location to obtain medications [30].
In Nepal, all residents do not have access to comprehensive health insurance coverage. Instead of going to the doctor early and preventing problems, patients choose the pre-doctor trial technique. As a result, steroid use and steroid-related diseases have increased. Many OTC medications are prescribed without a doctor's prescription in Nepal, and there are no clear distinctions between OTC and prescription drugs [31]. The lack of a proper law, as well as the lack of qualified pharmacists and paramedics providing drugs, are two of the most prevalent causes of steroid use [31]. Another factor is a scarcity of professionals and public understanding, particularly in Nepal's rural areas [32]. Steroids are available in a variety of forms, either alone or in combination with antibiotics and antifungals, all of which are commonly available over-the-counter at pharmacies [32].
In a sample of 19,464 dermatology OPD patients, 614 (3.15 percent), similar to an Indian study [33], indicated a history of using steroid-containing or other creams (ayurvedic/herbal/cosmetic) suspected of containing steroid without justification [32]. Sixty-six percent of patients were prescribed steroids by pharmacists. TCS was recommended by relatives/friends/neighbors in 19% of cases [32].
The easy availability of steroid over the counter at pharmacist shops across the country without a valid prescription in countries like Nepal and India is exacerbating the problem of abuse, as evidenced by various research [[34], [35], [36], [37], [38], [39], [40]].
4. Take away lesson
In recent years, steroid abuse has become increasingly common. Pharmaceutical industry manufacturing and promoting inappropriate fixed drug combinations containing steroids, unregulated over-the-counter supply and unrestricted sale of steroids, professional obliviousness (qualified and unqualified persons prescribing steroid), and general ignorance (layperson using steroid or advising friends/family to use it) are all factors contributing to this epidemic. As a result, it is past time to raise public awareness and educate prescribers (chemists and medical practitioners). Another important step would be to raise awareness of the problem with the government authorities and have them control the manufacture and over-the-counter selling of certain steroid mixtures. Topical steroids and their mixtures must be sold as "prescription-only" medications. Physician should opt to do medical history taking and correct irrational use of medicine. Chemist or pharmacist should avoid prescribing steroid without physician prescription. We all are responsible for such preventable mishaps and it's time to be accountable.
Ethical approval
Non applicable.
Sources of funding
This case report hasn't been funded by any person or any institutions.
Author contributions
1. Sandhya kiran Neupane, Department of Medicine, Shadhak Polyclinic, Bhaktapur, Nepal. First Author: she has Presented the case.
2. Prakash Paudel Jaishi,General Practitioner,Al Kamil Health center,Al Kamil, South Sharqiyah, Oman: second author (Guarantor).Editor of the article.
3. Divyaa Koirala, Department of Medicine, Danphe Health care, third Author: Editor of article.
4. Prabhat Kiran Neupane, Internship at Department of Medicine, Kist Medical College, Kathmandu. Fourth Author: Editor of the article.
Registration of research studies
-
1.
Name of the registry:
-
2.
Unique Identifying number or registration ID:
-
3.
Hyperlink to your specific registration (must be publicly accessible and will be checked):
Guarantor
Prakash Paudel Jaishi.
General Practitioner,Al Kamil Health center, Al Kamil, South Sharqiyah, Oman.
Consent
Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request.
Provenance and peer review
Not commissioned, externally peer reviewed.
Declaration of competing interest
There is no any conflicts of interest with this article.
Footnotes
Supplementary data to this article can be found online at https://doi.org/10.1016/j.amsu.2022.104697.
Appendix A. Supplementary data
The following is the Supplementary data to this article:
References
- 1.Fardet L., Petersen I., Nazareth I. Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 years. Rheumatology. 2011;50 doi: 10.1093/rheumatology/ker017. 1982–90. [PubMed] [Google Scholar] [DOI] [PubMed] [Google Scholar]
- 2.Fardet L., Flahault A., Kettaneh A., Tiev K.P., Généreau T., Tolédano C., et al. Corticosteroid-induced clinical adverse events: frequency, risk factors and patient's opinion. Br. J. Dermatol. 2007;157:142–148. doi: 10.1111/j.1365-2133.2007.07950.x. [PubMed] [Google Scholar] [DOI] [PubMed] [Google Scholar]
- 3.doi: 10.2147/CLEP.S44336.
- 4.Gender-related differences in the presentation and course of Cushing's disease, Pecori Giraldi F., Moro M., Cavagnini F. Study group on the hypothalamo-pituitary-adrenal Axis of the Italian society of endocrinology. J. Clin. Endocrinol. Metab. 2003 Apr;88(4):1554–1558. doi: 10.1210/jc.2002-021518. ([PubMed] [Ref list]) [DOI] [PubMed] [Google Scholar]
- 5.Ilias I., Torpy D.J., Pacak K., Mullen N., Wesley R.A., Nieman L.K. Cushing's syndrome due to ectopic corticotropin secretion: twenty years' experience at the National Institutes of Health. J. Clin. Endocrinol. Metab. 2005 Aug;90(8):4955–4962. doi: 10.1210/jc.2004-2527. [PubMed] [Ref list] [DOI] [PubMed] [Google Scholar]
- 6.Torpy D.J., Mullen N., Ilias I., Nieman L.K., Ann N.Y. Association of hypertension and hypokalemia with Cushing's syndrome caused by ectopic ACTH secretion: a series of 58 cases. Acad. Sci. 2002 Sep;970:134–144. doi: 10.1111/j.1749-6632.2002.tb04419.x. [PubMed] [Ref list] [DOI] [PubMed] [Google Scholar]
- 7.Sarlis N.J., Chanock S.J., Nieman L.K., Clin J. Cortisolemic indices predict severe infections in Cushing syndrome due to ectopic production of adrenocorticotropin. Endocrinol. Metab. 2000 Jan;85(1):42–47. doi: 10.1210/jcem.85.1.6294. [PubMed] [Ref list] [DOI] [PubMed] [Google Scholar]
- 8.Minetto M., Reimondo G., Osella G., Ventura M., Angeli A., Terzolo M. Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome. Osteoporos. Int. 2004 Nov;15(11):855–861. doi: 10.1007/s00198-004-1616-3. [PubMed] [Ref list] [DOI] [PubMed] [Google Scholar]
- 9.Neuropsychiatric manifestations of patients with Cushing's syndrome. Relationship to cortisol and adrenocorticotropic hormone levels. Starkman MN, Schteingart DE Arch. Intern. Med. 1981 Feb;141(2):215–219. [PubMed] [Ref list] [PubMed] [Google Scholar]
- 10.Steroid myopathy. Insidious cause of muscle weakness. Mandel S Postgrad. Med. 1982 Nov;72(5):207–210. doi: 10.1080/00325481.1982.11716260. 213-210. [PubMed] [Ref list] [DOI] [PubMed] [Google Scholar]
- 11.Rebuffé-Scrive M., Krotkiewski M., Elfverson J., Björntorp P.J. Muscle and adipose tissue morphology and metabolism in Cushing's syndrome. Clin. Endocrinol. Metabol. 1988 Dec;67(6):1122–1128. doi: 10.1210/jcem-67-6-1122. ([PubMed] [Ref list]) [DOI] [PubMed] [Google Scholar]
- 12.Lindsay J.R., Nansel T., Baid S., Gumowski J., Nieman L.K. Long-term impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission. J. Clin. Endocrinol. Metab. 2006 Feb;91(2):447–453. doi: 10.1210/jc.2005-1058. [PubMed] [Ref list] [DOI] [PubMed] [Google Scholar]
- 13.Pikkarainen L., Sane T., Reunsnen A. The survival and well-being of patients treated for Cushing's syndrome. J. Intern. Med. 1999;245:463–468. doi: 10.1046/j.1365-2796.1999.00483.x. [PubMed] [Google Scholar] [DOI] [PubMed] [Google Scholar]
- 14.Mishra A.K., Agarwal A., Gupta S., Agarwal G., Verma A.K., Mishra S.K. Outcome of adrenalectomy for Cushing's syndrome: experience from a tertiary care center. World J. Surg. 2007;31:1425–1432. doi: 10.1007/s00268-007-9067-6. [PubMed] [Google Scholar] [DOI] [PubMed] [Google Scholar]
- 15.Feelders R.A., Pulgar S.J., Kempel A., Pereira A.M. The burden of Cushing's disease: clinical and health-related quality of life aspects. Eur. J. Endocrinol. 2012;167:311–326. doi: 10.1530/EJE-11-1095. [PubMed] [Google Scholar] [DOI] [PubMed] [Google Scholar]
- 16.Pivonello R., De Leo M., Vitale P., et al. Pathophysiology of diabetes mellitus in Cushing's syndrome. Neuroendocrinology. 2010;92(Suppl 1):77–81. doi: 10.1159/000314319. [PubMed] [Google Scholar] [DOI] [PubMed] [Google Scholar]
- 17.Sharma S.T., Nieman L.K. Cushing's syndrome: all variants, detection, and treatment. Endocrinol Metab. Clin. N. Am. 2011;40:379–391. doi: 10.1016/j.ecl.2011.01.006. viii–ix. [PMC free article] [PubMed] [Google Scholar] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Arnaldi G., Scandali V.M., Trementino L., Cardinaletti M., Appolloni G., Boscaro M. Pathophysiology of dyslipidemia in Cushing's syndrome. Neuroendocrinology. 2010;92(Suppl 1):86–90. doi: 10.1159/000314213. [PubMed] [Google Scholar] [DOI] [PubMed] [Google Scholar]
- 19.Torpy D.J., Mullen N., Ilias I., Nieman L.K. Association of hypertension and hypokalemia with Cushing's syndrome caused by ectopic ACTH secretion: a series of 58 cases. Ann. N. Y. Acad. Sci. 2002;970:134–144. doi: 10.1111/j.1749-6632.2002.tb04419.x. [PubMed] [Google Scholar] [DOI] [PubMed] [Google Scholar]
- 20.Newell-Price J., Bertagna X., Grossman A.B., Nieman L.K. Cushing's syndrome. Lancet. 2006;367:1605–1617. doi: 10.1016/S0140-6736(06)68699-6. [PubMed] [Google Scholar] [DOI] [PubMed] [Google Scholar]
- 21.Mantero F., Terzolo M., Arnaldi G., et al. A survey on adrenal incidentaloma in Italy. Study group on adrenal tumors of the Italian society of endocrinology. J. Clin. Endocrinol. Metab. 2000;85:637–644. doi: 10.1210/jcem.85.2.6372. [PubMed] [Google Scholar] [DOI] [PubMed] [Google Scholar]
- 22.Hopkins R.L., Leinung M.C. Exogenous Cushing's syndrome and glucocorticoid withdrawal. Endocrinol Metab. Clin. N. Am. 2005;34:371–384. doi: 10.1016/j.ecl.2005.01.013. ([PubMed] [Google Scholar]) [DOI] [PubMed] [Google Scholar]
- 23.PMID 15251475.
- 24.Pmid 7784285.
- 25.Pmid 3753129.
- 26.Pmid 9250225.
- 27.Pmid 15755851.
- 28.Pmid 18377596.
- 29.Pmid 17452765.
- 30.A Research Report on Community Pharmacy Personal's Perception, Attitude and Dispensing Practice towards Antibiotics in Selected Districts of Terai Region of Province-1, Eastern Nepal.
- 31.10.1007/978-981-10-4609-4_18. [DOI]
- 32.10.31729/jnma.5271. [DOI]
- 33.Srivastava A. A clinicoepidemiological study of topical corticosteroid misuse at a tertiary care center. J. Dermatol. Treat. 2019 Nov;30(7):685–690. doi: 10.1080/09546634.2018.1544703. [DOI] [PubMed] [Google Scholar]
- 34.Dey V.K. Misuse of topical corticosteroids: a clinical study of adverse effects. Indian Dermatol. Online J. 2014 Oct;5(4):436–440. doi: 10.4103/2229-5178.142486. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Srivastava A. A clinicoepidemiological study of topical corticosteroid misuse at a tertiary care center. J. Dermatol. Treat. 2019 Nov;30(7):685–690. doi: 10.1080/09546634.2018.1544703. [DOI] [PubMed] [Google Scholar]
- 36.Meena S., Gupta L.K., Khare A.K., Balai M., Mittal A., Mehta S., et al. Topical corticosteroids abuse: a clinical study of cutaneous adverse effects. Indian J. Dermatol. 2017 Nov-Dec;62(6):675. doi: 10.4103/ijd.IJD_110_17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Thomas M., Wong C.C., Anderson P., Grills N. Magnitude, characteristics and consequences of topical steroid misuse in rural North India: an observational study among dermatology outpatients. BMJ Open. 2020 May 18;10(5) doi: 10.1136/bmjopen-2019-032829. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Chaudhary R.G., Rathod S.P., Jagati A., Baxi K., Ambasana A., Patel D. Prescription and usage pattern of topical corticosteroids among out-patient Attendees with dermatophyte infections and its analysis: a cross-sectional, survey-based study. Indian Dermatol. Online J. 2019 May-Jun;10(3):279–283. doi: 10.4103/idoj.IDOJ_335_18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Sharma R., Abrol S., Wani M. Misuse of topical corticosteroids on facial skin. A study of 200 patients. J. Dermatol. Case Rep. 2017 Mar 31;11(1):5–8. doi: 10.3315/jdcr.2017.1240. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Jha A.K., Sinha R., Prasad S. Misuse of topical corticosteroids on the face: a cross-sectional study among dermatology outpatients. Indian Dermatol. Online J. 2016 Jul-Aug;7(4):259–263. doi: 10.4103/2229-5178.185492. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.






